Alector
X
Alector launches $208m fundraiser for Alzheimer’s R&D with AbbVie
https://pharmaphorum.com/news/alector-launches-208m-fundraiser-as/
Alector kicks off biotech IPOs after US government shutdown
Richard Staines
Alector, Alzheimer's, IPO, neurology
0 Comment
X
Alector kicks off biotech IPOs after US government shutdown
https://pharmaphorum.com/news/alector-kicks-off-biotech-ipos-after-us-government-shutdown/
AbbVie/ News/ R&D/ Top stories
AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s
Marco Ricci
AbbVie, Alector, Alzheimer's disease, immuno-neurology
0 Comment
Partnership will use novel approach to treating Alzheimer’s.
X
AbbVie signs $225m ‘immunoneurology’ deal to tackle Alzheimer’s
https://pharmaphorum.com/news/abbvie-immunoneurology-alzheimers/